Mark Deleon
Hematology/oncology in Santa Rosa Beach, FL
About Mark Deleon
Mark Deleon is a clinician specializing in hematology/oncology practicing in Santa Rosa Beach, FL, a graduate of Uniformed Services Uhs Fe Hebert School of Med (1994). Affiliated with Ascension Sacred Heart Bay, Ascension Sacred Heart Pensacola, Hca Florida Twin Cities Hospital and 2 more. Treated 470 Medicare patients in 2024.
| Specialty | Hematology/oncologyOther hematology/oncology doctors in Santa Rosa Beach |
|---|---|
| Education | Uniformed Services Uhs Fe Hebert School of Med, 1994CMS Doctors and Clinicians |
| Gender | Male |
| NPI number | 1174557649National Provider Identifier (CMS NPPES), issued July 2006 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
| Telehealth | Offers telehealth servicesCMS Doctors and Clinicians |
Where Mark Deleon practices
- Sacred Heart Medical Oncology Group 27 Mack Bayou Loop, Suite 1000, Santa Rosa Beach, FL 32459 (850) 622-0873 · Directions · group of 398 clinicians
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Mark Deleon's specialties and state licenses
| Specialty (NPPES) | License |
|---|---|
| Hematology & Oncology Primary | FL ME146938 |
| Hematology & Oncology | TX L0125 |
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Hospital affiliations of Mark Deleon
- Ascension Sacred Heart BayHospital · Panama City, FL
- Ascension Sacred Heart PensacolaHospital · Pensacola, FL
- Hca Florida Twin Cities HospitalHospital · Niceville, FL
- North Okaloosa Medical CenterHospital · Crestview, FL
- Sacred Heart Hospital on the Emerald CoastHospital · Miramar Beach, FL
CMS Facility Affiliation data: facilities where the clinician bills Medicare.
Mark Deleon's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 675 | $94.71 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 365 | $64.36 |
| Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more | 94 | $34.28 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 65 | $129.78 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 63 | $140.94 |
| New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | 39 | $80.31 |
| New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | 26 | $173.05 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $71.91 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Mark Deleon's Medicare quality score (MIPS 2024)
The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as apm. Source: CMS Care Compare, PY 2024 clinician public reporting.
Payments from drug and device companies to Mark Deleon (2025)
$2,299.29 in 109 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 108 | $2,276.19 |
| Education | 1 | $23.10 |
Paying companies: AstraZeneca Pharmaceuticals LP ($225.88), E.R. Squibb & Sons, L.L.C. ($143.26), NOVARTIS PHARMACEUTICALS CORPORATION ($141.33), Pfizer Inc. ($139.83), GlaxoSmithKline, LLC. ($127.22), AbbVie Inc. ($115.69).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Mark Deleon
What kind of clinician is Mark Deleon?
Mark Deleon is listed as a clinician specializing in hematology/oncology.
Where does Mark Deleon practice?
Sacred Heart Medical Oncology Group at 27 Mack Bayou Loop, Suite 1000, Santa Rosa Beach, FL 32459.
What is the office phone number for Mark Deleon?
The listed office number is (850) 622-0873. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Mark Deleon?
The National Provider Identifier is 1174557649.
Does Mark Deleon accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Which hospitals is Mark Deleon affiliated with?
Ascension Sacred Heart Bay, Ascension Sacred Heart Pensacola, Hca Florida Twin Cities Hospital, North Okaloosa Medical Center, Sacred Heart Hospital on the Emerald Coast.
Where did Mark Deleon go to medical school?
Uniformed Services Uhs Fe Hebert School of Med, graduating in 1994.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2020-12-02 |
| Facility affiliations | Hospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| MIPS | Quality payment program scores.CMS clinician public reporting, PY 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.